Minireviews
Copyright ©The Author(s) 2017.
World J Gastrointest Endosc. Aug 16, 2017; 9(8): 378-388
Published online Aug 16, 2017. doi: 10.4253/wjge.v9.i8.378
Table 3 Role of endoscopic ultrasonography in the evaluation of the outcome of endoscopic therapeutics for esophageal varices
Ref.Study designEndoscopic findingsEUS findings
Masalaite et al[35]Prospective The role of EUS in predicting the recurrence/rebleeding of esophageal varices: EBL (n = 40)Recurrence of esophageal varices: 19 (47.5%) within 12 mo of EBLEUS independent prognostic factors for variceal recurrence: Severe esophageal collaterals (OR= 24.39) multiple esophageal collaterals (OR = 24.39)
Lo et al[39]Prospective The role of EUS in predicting the recurrence of esophageal varices: ES (n = 35) vs EBL (n = 44)Recurrence of esophageal varices: 43% ES vs 70% EBLParaesophageal varices: 51% ES vs 86% EBL
de Paulo et al[40]Prospective The role of EUS-guided ES: ES (n = 25) vs EUS-guided ES (n = 25) of esophageal collateral vesselsMean number of sessions until eradication: 4.3 ES group vs 4.1 for the EUS-ES Recurrence of esophageal varices: 16.7% ES vs 8.3% EUS-ESEsophageal collaterals at the end of the sclerotherapy program: 8 patients in ES vs 0 patients in EUS-ES